RTW Biotech Opportunities (LON:RTW – Get Free Report) traded down 0.6% on Wednesday . The stock traded as low as GBX 1.52 ($0.02) and last traded at GBX 1.53 ($0.02). 78,428 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 556,291 shares. The stock had previously closed at GBX 1.54 ($0.02).
RTW Biotech Opportunities Trading Down 0.6 %
The firm has a fifty day simple moving average of GBX 1.56 and a two-hundred day simple moving average of GBX 1.42. The firm has a market cap of £5.89 million, a PE ratio of 4.25 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- How to Calculate Options Profits
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
